Home › Funds › SAPIENT CAPITAL LLC › ASND

SAPIENT CAPITAL LLC position in ASND

ASCENDIS PHARMA A/S · Health Care

SAPIENT CAPITAL LLC reported holding 95,721 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$21.8M, representing 0.29% of its reported portfolio and ranking #44 among its reported holdings. SAPIENT CAPITAL LLC has disclosed ASND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)95.72K sh
Reported value held$21.81M
Portfolio Weight0.29%
First reportedQ2 2026
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How SAPIENT CAPITAL LLC's ASND position evolved

SAPIENT CAPITAL LLC first disclosed a stake in ASND in Q2 2026 at 92,162 shares (US$24.6M). Across 2 filings, SAPIENT CAPITAL LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 95,721 shares valued at US$21.8M — an increase of 3,559 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 92.16K $24.58M New
Q3 2026 95.72K $21.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has SAPIENT CAPITAL LLC held ASND?

SAPIENT CAPITAL LLC has disclosed ASND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is SAPIENT CAPITAL LLC's current position in ASND?

As of Q3 2026, SAPIENT CAPITAL LLC holds 95.72K shares of ASND (ASCENDIS PHARMA A/S), valued at $21.81M, representing 0.29% of its reported portfolio and ranking #44.

Has SAPIENT CAPITAL LLC been buying or selling ASND?

In the latest 13F filing (Q3 2026), SAPIENT CAPITAL LLC increased its position in ASND.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.